Form 4: Arteris CFO Nicholas Hawkins Sells Shares to Cover Tax Obligations and Under 10b5-1 Plan
SEC Form 4
Arteris CFO Nicholas Hawkins sold a total of 14,387 shares of common stock on January 2, 2025, to cover tax liabilities and under a pre-arranged 10b5-1 trading plan.
Summary
- Arteris' Chief Financial Officer, Nicholas B. Hawkins, executed multiple sales of company stock on January 2, 2025.
- A total of 1,682 shares were sold at $11.4133 per share to cover tax obligations related to the vesting of restricted stock units.
- An additional 1,705 shares were sold at $11.4133 per share.
- Furthermore, 11,000 shares were sold at a weighted average price of $11.0656 per share, with individual prices ranging from $10.00 to $11.89.
- These sales were partially executed under a pre-arranged 10b5-1 trading plan adopted on May 20, 2024.
- Following these transactions, Mr. Hawkins directly owns 169,868 shares of Arteris common stock.
Sentiment
Score: 6
Explanation: The document reflects a routine transaction (stock sales by an executive) that is not inherently positive or negative. The use of a 10b5-1 plan adds a layer of transparency, which is generally viewed favorably.
Positives
- The sales to cover tax obligations are a normal part of executive compensation.
- The use of a 10b5-1 trading plan indicates a pre-planned and transparent approach to stock sales.
Negatives
- The sale of shares by a high-ranking executive could be perceived negatively by some investors, although it is a common practice.
Risks
- Executive stock sales, even when planned, can sometimes create short-term downward pressure on the stock price.
- There is a risk that further sales by the executive could occur under the 10b5-1 plan.
Industry Context
Executive stock sales are a common occurrence in publicly traded companies, often related to compensation and tax planning. The use of a 10b5-1 plan is a standard practice to avoid accusations of insider trading.
Comparison to Industry Standards
- The use of 10b5-1 trading plans is a common practice among executives at publicly traded companies, including those in the semiconductor and technology sectors, such as ARM Holdings, Synopsys, and Cadence Design Systems.
- These plans allow executives to sell shares at predetermined times and prices, mitigating the risk of insider trading allegations.
- The sale of shares to cover tax liabilities is also a standard practice, particularly after the vesting of restricted stock units, and is not unique to Arteris or its executives.
Stakeholder Impact
- The stock sales may have a minor impact on the share price in the short term.
- The transactions are unlikely to have a significant impact on employees, customers, or suppliers.
Key Dates
| Date | Description |
|---|---|
| 05/20/2024 | Date the 10b5-1 trading plan was adopted by Nicholas Hawkins. |
| 01/02/2025 | Date of the stock sales by Nicholas Hawkins. |
| 01/06/2025 | Date the Form 4 was signed. |
Keywords
Arteris, Nicholas Hawkins, CFO, stock sale, 10b5-1 plan, insider trading, tax liability, executive compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.